Bloqueadores de los Canales del Calcio

Canal de calcio - los bloqueadores son usados para tratar la hipertensión, angina, arritmias cardiacas y otras enfermedades cardiacas relacionadas.

Las medicinas en esta familia incluyen

  • amlodipina (Norvasc)
  • Clorohidrato de bepridil (Vascor)
  • diltiazem (Cardizem, Cardizem CD, Cardizem SR, Dilacor XR, Tiamate, Tiazac)
  • felodipino (Plendil)
  • isradipina (Dynacirc, Dynacirc CR)
  • hidrocloruro de nicardipina (Cardene, Cardene SR)
  • nifedipina (Procardia, Procardia XL, Adalat, Adalat CC)
  • nimodipina (Nimotop)
  • nisoldipina (Sular)
  • verapamil (Calan, Calan SR, Covera-HS, Isoptin, Isoptin SR, Verelan)
  • y otros
Calcio, Vitamina D
Posible Reducción de la Acción del Medicamento

Tomar suplementos de calcio y vitamina D podría interferir con algunos de los efectos de los bloqueadores del canal de calcio.1 - 7

Ginkgo Biloba

Según un estudio en ratas, el extracto de ginkgo puede causar que el cuerpo metabolice nicardipina (un bloqueador del canal de calcio) más rápidamente, reduciendo de esa manera sus efectos.8

Ultima revisión August 2013 por EBSCO CAM Review Board
Last Updated: 08/22/2013

EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.

This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.

To send comments or feedback to our Editorial Team regarding the content please email us at healthlibrarysupport@ebsco.com. Our Health Library Support team will respond to your email request within 2 business days.

Copyright ©  EBSCO Information Services
All rights reserved.
Privacy Policy | Editorial Policy